Echinacoside ameliorates D-galactosamine plus lipopolysaccharide-induced acute liver injury in mice via inhibition of apoptosis and inflammation

Scandinavian Journal of Gastroenterology

Volumn 49, Issue 8, 2014, Pages 993-1000

  Li, Xiuhui ^a   Gou, Chunyan ^a   Yang, Huasheng ^a   Qiu, Jinpeng ^a   Gu, Tao ^b   Wen, Tao ^a,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b FIRST HOSPITAL OF QINHUANGDAO   (China)

^c Beijing Institute of Hepatology   (China)

Author keywords

Acute liver injury; Apoptosis; D galactosamine; Echinacoside; inflammation; Lipopolysaccharide

Indexed keywords

ALANINE AMINOTRANSFERASE; ECHINACOSIDE; GALACTOSAMINE; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA; ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; GLYCOSIDE;

ACUTE LIVER INJURY; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CISTANCHE SALSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; HISTOPATHOLOGY; LIVER FATTY DEGENERATION; LIVER HEMORRHAGE; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; MALE; MEDIATOR RELEASE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NUCLEOSOME; PRIORITY JOURNAL; ANIMAL; BLOOD; C57BL MOUSE; DISEASE MODEL; DRUG EFFECTS; DRUG-INDUCED LIVER INJURY; INFLAMMATION; INTRAPERITONEAL DRUG ADMINISTRATION; LIVER CELL; TREATMENT OUTCOME;

ALANINE TRANSAMINASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; DRUG-INDUCED LIVER INJURY; GALACTOSAMINE; GLYCOSIDES; HEPATOCYTES; INFLAMMATION; INJECTIONS, INTRAPERITONEAL; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; TREATMENT OUTCOME;

EID: 84904421367     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.3109/00365521.2014.913190     Document Type: Article

References (28)

1. Adams DH, Ju C, Ramaiah SK, Uetrecht J, Jaeschke H. Mechanisms of immune-mediated liver injury. Toxicol Sci 2010;115:307-21.
2. Lee WM. Etiologies of acute liver failure. Semin Liver Dis 2008;28:142-52. (Pubitemid 351632954)
3. Ozaslan E. Drug-induced autoimmune hepatitis: An easily reversible type of liver fibrosis? Hepatology 2011;53:370.
4. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002;65:166-76. (Pubitemid 34121108)
5. Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 2007;35:757-66. (Pubitemid 47613608)
6. Rolando N, Wade J, Davalos M, Wendon J, Philpott-Howard J, Williams R. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000;32:734-9.
7. Kuang R, Sun Y, Yuan W, Lei L, Zheng X. Protective effects of echinacoside, one of the phenylethanoid glycosides, on H (2)O(2)-induced cytotoxicity in PC12 cells. Planta Med 2009;75:1499-504.
8. Deng M, Zhao JY, Tu PF, Jiang Y, Li ZB, Wang YH. Echinacoside rescues the SHSY5Y neuronal cells from TNFalpha-induced apoptosis. Eur J Pharmacol 2004;505: 11-18. (Pubitemid 39535671)
9. Zhang Y, Xing J, Ai T, Wen T, Guan L, Zhao J. Protection of echinacoside against acute lung injury caused by oleic acid in rats. Free Radic Res 2007;41:798-805. (Pubitemid 46995261)
10. Wu Y, Li L, Wen T, Li Y-Q. Protective effects of echinacoside on carbon tetrachloride-induced hepatotoxicity in rats. Toxicology 2007;232:50-6. (Pubitemid 46283170)
11. Malle E, Furtmller PG, Sattler W, Obinger C. Myeloperoxidase: A target for new drug development? Br J Pharmacol 2007;152:838-54. (Pubitemid 350100486)
12. Martin-Murphy B V, Holt MP, Ju C. The role of damage associated molecular pattern molecules in acetaminopheninduced liver injury in mice. Toxicol Lett 2010;192: 387-94.
13. Holdenrieder S, Stieber P. Clinical use of circulating nucleosomes. Crit Rev Clin Lab Sci 2009;46:1-24.
14. Zhou R-R, Liu H-B, Peng J-P, Huang Y, Li N, Xiao M-F, et al. High mobility group box chromosomal protein 1 in acute-on-chronic liver failure patients and mice with ConA-induced acute liver injury. Exp Mol Pathol 2012;93: 213-19.
15. Abrams ST, Zhang N, Manson J, Liu T, Dart C, Baluwa F, et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med 2013;187:160-9.
16. Xu J, Zhang X, Monestier M, Esmon NL, Esmon CT. Extracellular histones are mediators of death through TLR2 and TLR4 in mouse fatal liver injury. J Immunol 2011;187:2626-31.
17. Takano K, Shinoda M, Tanabe M, Miyasho T, Yamada S, Ono S, et al. Protective effect of high-mobility group box 1 blockade on acute liver failure in rats. Shock 2010;34:573-9.
18. Craig DGN, Lee P, Pryde EA, Masterton GS, Hayes PC, Simpson KJ. Circulating apoptotic and necrotic cell death markers in patients with acute liver injury. Liver Int 2011;31: 1127-36.
19. Das J, Ghosh J, Manna P, Sil PC. Protective role of taurine against arsenic-induced mitochondria-dependent hepatic apoptosis via the inhibition of PKCdelta-JNK pathway. PLoS One 2010;5:e12602.
20. Jaeschke H, Hasegawa T. Role of neutrophils in acute inflammatory liver injury. Liver Int 2006;26:912-19. (Pubitemid 44323408)
21. Wen Z, Liu Y, Li F, Ren F, Chen D, Li X, et al. Circulating histones exacerbate inflammation in mice with acute liver failure. J Cell Biochem 2013;114:2384-91.
22. Harris HE, Andersson U, Pisetsky DS. HMGB1: A multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 2012;8:195-202.
23. Gong Q, Zhang H, Li J, Duan L, Zhong S, Kong X, et al. High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice. J Mol Med 2010;88: 1289-98.
24. Chayama K, Hayes CN, Hiraga N, Abe H, Tsuge M, Imamura M. Animal model for study of human hepatitis viruses. J Gastroenterol Hepatol 2011;26:13-18.
25. Ni H-M, Chen X, Ding W-X, Schuchmann M, Yin X-M. Differential roles of JNK in ConA/GalN and ConA-induced liver injury in mice. Am J Pathol 2008;173:962-72.
26. Evankovich J, Cho SW, Zhang R, Cardinal J, Dhupar R, Zhang L, et al. High mobility group box 1 release from hepatocytes during ischemia and reperfusion injury is mediated by decreased histone deacetylase activity. J Biol Chem 2010;285:39888-97.
27. Oshima G, Shinoda M, Tanabe M, Ebinuma H, Nishiyama R, Takano K, et al. Increased plasma levels of high mobility group box 1 in patients with acute liver failure. Eur Surg Res 2012;48:154-62.
28. Huang H, Evankovich J, Yan W, Nace G, Zhang L, Ross M, et al. Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice. Hepatology 2011;54:999-1008.